Sun Pharmaceuticals Industries Ltd

Sun Pharma.Inds. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sun Pharmaceuticals Industries Ltd

₹ 1,524 0.26%
02 Jul - close price
sunpharma.com BSE: 524715 NSE: SUNPHARMA
About

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.[1] It is the largest pharmaceutical company in India.[2]

Key Points

Product Offerings
The company produces a comprehensive and diverse portfolio of generic and specialty medicines targeting wide spectrum of chronic and acute treatments. Its product portfolio includes generics, branded generics, specialty, difficult-to-make technology intensive products, anti-retrovirals, APIs and intermediates.[1] It offers medicines in all form of dosages i.e. injectables, sprays, ointments, creams, liquids, tablets and capsules.[2]

Website BSE NSE
  • Market Cap ₹ 3,65,671 Cr.
  • Current Price ₹ 1,524
  • High / Low ₹ 1,639 / 1,028
  • Stock P/E 36.6
  • Book Value ₹ 265
  • Dividend Yield 0.89 %
  • ROCE 17.3 %
  • ROE 16.7 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 23.4% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 46.6%

Cons

  • The company has delivered a poor sales growth of 10.8% over past five years.
  • Tax rate seems low
  • Working capital days have increased from 96.5 days to 142 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
8,523 9,719 9,626 9,863 9,447 10,762 10,952 11,241 10,931 11,941 12,192 12,381 11,983
6,475 6,898 6,996 7,257 7,106 7,877 7,996 8,237 8,129 8,609 9,013 8,904 8,948
Operating Profit 2,048 2,821 2,630 2,606 2,340 2,884 2,957 3,004 2,802 3,332 3,179 3,477 3,035
OPM % 24% 29% 27% 26% 25% 27% 27% 27% 26% 28% 26% 28% 25%
-562 -479 223 433 -3,822 2 85 174 202 -118 294 180 504
Interest 30 35 36 19 37 14 19 46 93 81 49 35 74
Depreciation 553 503 530 554 556 588 610 660 672 651 633 622 650
Profit before tax 903 1,804 2,287 2,466 -2,076 2,285 2,412 2,471 2,240 2,481 2,791 3,000 2,816
Tax % 6% 22% 9% 14% -7% 8% 6% 11% 10% 19% 14% 14% 5%
842 1,404 2,086 2,126 -2,227 2,093 2,256 2,181 1,983 2,006 2,385 2,561 2,659
EPS in Rs 3.73 6.02 8.53 8.58 -9.49 8.59 9.43 9.03 8.27 8.43 9.90 10.52 11.06
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
11,131 16,080 27,392 28,487 31,578 26,489 29,066 32,838 33,498 38,654 43,886 48,497
6,346 9,078 19,498 20,313 21,476 20,858 22,689 25,855 25,028 28,397 32,109 35,474
Operating Profit 4,784 7,003 7,894 8,174 10,102 5,631 6,377 6,983 8,470 10,258 11,777 13,023
OPM % 43% 44% 29% 29% 32% 21% 22% 21% 25% 27% 27% 27%
-90 -1,968 283 -42 610 -135 -258 382 -3,449 -3,505 333 860
Interest 43 44 579 523 400 518 555 303 141 127 172 238
Depreciation 336 409 1,195 1,038 1,265 1,500 1,753 2,053 2,080 2,144 2,529 2,557
Profit before tax 4,315 4,581 6,403 6,571 9,048 3,479 3,810 5,010 2,799 4,481 9,408 11,088
Tax % 20% 15% 14% 14% 13% 26% 16% 16% 18% 24% 9% 13%
3,469 3,879 5,476 5,658 7,846 2,542 3,208 4,172 2,272 3,389 8,513 9,610
EPS in Rs 14.40 15.17 21.92 18.89 29.03 8.73 11.11 15.69 12.10 13.64 35.32 39.91
Dividend Payout % 9% 10% 14% 5% 12% 23% 25% 25% 62% 73% 33% 34%
Compounded Sales Growth
10 Years: 12%
5 Years: 11%
3 Years: 13%
TTM: 11%
Compounded Profit Growth
10 Years: 8%
5 Years: 23%
3 Years: 25%
TTM: 16%
Stock Price CAGR
10 Years: 8%
5 Years: 32%
3 Years: 31%
1 Year: 45%
Return on Equity
10 Years: 14%
5 Years: 14%
3 Years: 16%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 104 207 207 241 240 240 240 240 240 240 240 240
Reserves 14,886 18,318 25,431 32,742 36,400 38,074 41,169 45,025 46,223 47,771 55,755 63,427
260 2,561 8,996 8,497 9,832 10,385 10,514 8,315 3,869 1,290 6,886 3,274
5,128 8,009 14,089 13,948 14,624 15,598 12,666 14,615 17,291 20,474 17,831 18,522
Total Liabilities 20,377 29,095 48,723 55,428 61,095 64,297 64,590 68,194 67,622 69,776 80,712 85,463
5,647 6,817 12,682 15,872 17,675 18,853 21,837 22,847 21,553 22,665 24,420 27,458
CWIP 563 842 2,039 2,175 2,801 2,465 1,411 1,220 1,567 1,287 4,973 1,108
Investments 2,412 2,786 2,716 1,830 1,192 7,143 7,903 10,143 9,612 12,849 14,830 15,026
11,756 18,650 31,286 35,550 39,427 35,837 33,439 33,984 34,890 32,975 36,489 41,872
Total Assets 20,377 29,095 48,723 55,428 61,095 64,297 64,590 68,194 67,622 69,776 80,712 85,463

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3,357 3,959 5,616 6,686 7,082 3,907 2,196 6,555 6,170 8,985 4,959 12,135
-2,375 -2,176 -1,502 -3,949 -4,186 -3,104 -310 -2,225 407 -5,556 -7,220 -690
-665 507 -1,187 -1,889 -2,285 -1,539 -2,731 -5,715 -5,980 -5,193 2,376 -6,710
Net Cash Flow 316 2,290 2,927 848 611 -736 -844 -1,386 596 -1,765 115 4,735

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 79 50 68 87 83 108 112 105 99 99 95 85
Inventory Days 454 410 307 370 307 338 366 311 378 315 360 338
Days Payable 186 174 178 207 197 234 192 142 167 158 194 194
Cash Conversion Cycle 347 286 197 251 193 212 285 274 310 255 261 229
Working Capital Days 111 126 76 104 73 79 137 112 84 55 93 142
ROCE % 32% 34% 23% 18% 20% 10% 10% 10% 13% 17% 16%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48%
11.50% 12.07% 13.00% 14.44% 14.95% 16.00% 16.87% 16.88% 16.48% 16.78% 17.08% 17.72%
21.97% 21.73% 20.99% 20.02% 19.66% 19.64% 19.08% 19.18% 19.65% 19.56% 19.42% 18.71%
0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.06% 0.06% 0.09% 0.10% 0.11% 0.11%
12.05% 11.72% 11.53% 11.06% 10.91% 9.80% 9.52% 9.38% 9.28% 9.05% 8.92% 8.97%
No. of Shareholders 7,57,3666,75,9086,80,8006,62,3846,47,1676,43,5126,32,3376,25,2526,24,5616,16,5886,12,6266,31,392

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls